dokumendiregister.ee
OtsingAsutusedMCP
dokumendiregister.eeAsutusedEesti avalike dokumendiregistrite otsing · nimistu.ee andmetel
Otsing›Sotsiaalministeerium
Sissetulev kiriAvalik

Pöördumine

Sotsiaalministeerium · 30. aprill 2021
Viit
1.4-2/1499-1
Registreeritud
30. aprill 2021
Dokumendi liik
Sissetulev kiri
Adressaat
Eesti Vabariigi Alaline Esindus EL juures
Saabumis/saatmisviis
DVK
Funktsioon
1.4 EL otsustusprotsess ja rahvusvaheline koostöö
Sari
1.4-2 Rahvusvahelise koostöö korraldamisega seotud kirjavahetus (Arhiiviväärtuslik)
Toimik
1.4-2/2021
Vastutaja
Agnes Alajõe (Sotsiaalministeerium, Kantsleri vastutusvaldkond, Euroopa Liidu ja väliskoostöö osakond)
Lahendamise tähtaeg
30. mai 2021

Failid

  • 📎499-1_edastamismeil.pdf906 KB
  • 📎499-1_kaaskiri_AEEL_Kiik_Kruuse_29042021.pdf254 KB
  • 📎499-1_Letter_Ministers_EE_Kiik.pdf271 KB
  • 📎499-1_Letter_Ministers_EE_Kruuse.pdf271 KB

Sisu (failidest)

Ref. Ares(2021)2855935 - 29/04/2021 STELLA KYRIAKIDES Rue de la Loi, 200 MEMBER OF THE EUROPEAN COMMISSION B-1049 Brussels – Berl 10/380 HEALTH AND FOOD SAFETY [email protected] Brussels, 29 April 2021 Dear Minister Kiik, I am writing further to the correspondence with my predecessor (Ares(2019)692252, dated 6 February 2019), concerning the implementation of Regulation (EU) 2019/6 of the European Parliament and of the Council of 11 December 2018 on veterinary medicinal products and repealing Directive 2001/82/EC (OJ L 4, 7.1.2019, p. 43, hereinafter ‘the VMP Regulation’), which will start applying from 28 January 2022. In that letter, my predecessor highlighted both the need for Member States to earmark adequate resources for the implementation of the VMP Regulation and the importance of your national contributions to the Union product database to enable the regulatory processes laid down in the VMP Regulation as of the date of its application. Let me start by thanking you for the excellent cooperation in and your invaluable input to the ongoing process of implementation of the VMP Regulation. The expertise and involvement of the Member States have been key for our progress so far and we greatly appreciate your contribution. The Commission remains committed to give effect to the new and modern legal framework on veterinary medicinal products, which will also contribute to achieving the objective of the Farm to Fork strategy to reduce overall EU sales of antimicrobials for farmed animals and in aquaculture by 50% by 2030. As you are aware, the implementation of the VMP Regulation is a major undertaking with some 25 delegated and implementing acts to be adopted. Mr Tanel Kiik Minister of Health and Labour, Social Affairs Suur-Ameerika 1 10122 Tallinn I am pleased to inform you that, overall, the Commission is on track to adopt the required secondary legislation in time. Several delegated and implementing acts have already been published in the Official Journal of the European Union. The remaining acts, which need to be in place before or by the date of application of the VMP Regulation, are also advancing well. The establishment of the Union product database has progressed at the European Medicines Agency with the involvement of the entire network and the functionality for Member States to provide their national information to populate the Union product database is expected to be operational towards the end of the second quarter of this year. Let me emphasise that we have now reached a point where the contribution of each and every Member State will be critical for the success of the implementation of the VMP Regulation. That is why I would like to reiterate the call to prioritise the allocation of sufficient resources and to focus efforts on addressing the various aspects of the implementation of the VMP Regulation. These include: - that Member States prepare effectively at national level for the upcoming changes and ease the transition to the new legislative framework. This may necessitate timely amendments to or adaption of national legislation or processes. - that Member States map their national information on veterinary medicinal products and upload it promptly to the Union product database. In the case of veterinary medicinal products authorised under the decentralised or mutual recognition procedures, the effectiveness of that process will largely depend on Reference Member States uploading the common information early in the process so that the Member States Concerned can subsequently upload their national data. That initial input of information to the Union product database is essential for enabling a number of regulatory processes and reducing administrative burden once the VMP Regulation becomes applicable. In addition, the input provided by the Member States and contained in the Union product database will enhance the Single Market, increase the availability of veterinary medicinal products and provide information to the public. I trust that the required provisions are made available and that preparations are ongoing in your country to ensure seamless and timely implementation of the VMP Regulation. Our efforts now need to be even more focused and I count on your continued support to make the implementation of the VMP Regulation our common success. My colleagues in the Directorate-General for Health and Food Safety of the European Commission and I personally are strongly committed to successfully delivering on the implementation of the VMP Regulation. We remain available and willing to support the Member States in their work. Yours sincerely, Electronically signed on 29/04/2021 07:52 (UTC+02) in accordance with article 11 of Commission Decision C(2020) 4482 Tanel Kiik Tervise- ja tööminister 29.04.2021 nr 10.1-13/499-1 Sotsiaalministeerium Urmas Kruuse Maaeluminister Maaeluministeerium Austatud ministrid Edastame teile Euroopa Komisjoni voliniku Stella Kyriakidese 29.04.2021 kirjad nr Ares(2021) 2855935 seoses veterinaarravimite määruse rakendamisega. Lugupidamisega Marten Kokk Esinduse asejuht Coreper I küsimustes Lisad: 1. voliniku kiri minister Kiigele 2 lk 2. voliniku kiri minister Kruusele 2 lk Tiiu Noobel +32 2227 4337 [email protected] Rue Guimard 11/13 1040 Brüssel Tel: +32 2 227 39 10 [email protected] https://eu.mfa.ee/et/ Ref. Ares(2021)2855935 - 29/04/2021 STELLA KYRIAKIDES Rue de la Loi, 200 MEMBER OF THE EUROPEAN COMMISSION B-1049 Brussels – Berl 10/380 HEALTH AND FOOD SAFETY [email protected] Brussels, 29 April 2021 Dear Minister Kruuse, I am writing further to the correspondence with my predecessor (Ares(2019)692252, dated 6 February 2019), concerning the implementation of Regulation (EU) 2019/6 of the European Parliament and of the Council of 11 December 2018 on veterinary medicinal products and repealing Directive 2001/82/EC (OJ L 4, 7.1.2019, p. 43, hereinafter ‘the VMP Regulation’), which will start applying from 28 January 2022. In that letter, my predecessor highlighted both the need for Member States to earmark adequate resources for the implementation of the VMP Regulation and the importance of your national contributions to the Union product database to enable the regulatory processes laid down in the VMP Regulation as of the date of its application. Let me start by thanking you for the excellent cooperation in and your invaluable input to the ongoing process of implementation of the VMP Regulation. The expertise and involvement of the Member States have been key for our progress so far and we greatly appreciate your contribution. The Commission remains committed to give effect to the new and modern legal framework on veterinary medicinal products, which will also contribute to achieving the objective of the Farm to Fork strategy to reduce overall EU sales of antimicrobials for farmed animals and in aquaculture by 50% by 2030. As you are aware, the implementation of the VMP Regulation is a major undertaking with some 25 delegated and implementing acts to be adopted. Mr Urmas Kruuse Minister of Rural Affairs Lai tn 39//Lai tn 41 15056 Tallinn I am pleased to inform you that, overall, the Commission is on track to adopt the required secondary legislation in time. Several delegated and implementing acts have already been published in the Official Journal of the European Union. The remaining acts, which need to be in place before or by the date of application of the VMP Regulation, are also advancing well. The establishment of the Union product database has progressed at the European Medicines Agency with the involvement of the entire network and the functionality for Member States to provide their national information to populate the Union product database is expected to be operational towards the end of the second quarter of this year. Let me emphasise that we have now reached a point where the contribution of each and every Member State will be critical for the success of the implementation of the VMP Regulation. That is why I would like to reiterate the call to prioritise the allocation of sufficient resources and to focus efforts on addressing the various aspects of the implementation of the VMP Regulation. These include: - that Member States prepare effectively at national level for the upcoming changes and ease the transition to the new legislative framework. This may necessitate timely amendments to or adaption of national legislation or processes. - that Member States map their national information on veterinary medicinal products and upload it promptly to the Union product database. In the case of veterinary medicinal products authorised under the decentralised or mutual recognition procedures, the effectiveness of that process will largely depend on Reference Member States uploading the common information early in the process so that the Member States Concerned can subsequently upload their national data. That initial input of information to the Union product database is essential for enabling a number of regulatory processes and reducing administrative burden once the VMP Regulation becomes applicable. In addition, the input provided by the Member States and contained in the Union product database will enhance the Single Market, increase the availability of veterinary medicinal products and provide information to the public. I trust that the required provisions are made available and that preparations are ongoing in your country to ensure seamless and timely implementation of the VMP Regulation. Our efforts now need to be even more focused and I count on your continued support to make the implementation of the VMP Regulation our common success. My colleagues in the Directorate-General for Health and Food Safety of the European Commission and I personally are strongly committed to successfully delivering on the implementation of the VMP Regulation. We remain available and willing to support the Member States in their work. Yours sincerely, Electronically signed on 29/04/2021 07:52 (UTC+02) in accordance with article 11 of Commission Decision C(2020) 4482 Tiiu Noobel From: Elen Nurme Sent: Thursday, 29 April 2021 16:44 To: Tiiu Noobel; Kersti Neeme Subject: FW: FW: Letter from EU Commissioner Stella Kyriakides to the Minister of Health and Labour, Social Affairs, Mr Tanel Kiik and to the Minister of Rural Affairs, Mr Urmas Kruuse. Attachments: Cover Letter EE.docx.pdf; Letter Ministers EE - Kiik.docx (1).pdf; Letter Ministers EE - Kruuse.docx (1).pdf From: Algis Kokka <[email protected]> Sent: Thursday, April 29, 2021 4:41 PM To: Liina Tomlinson <[email protected]>; Reili Kivilo <[email protected]>; Triin Uusberg (SoM) <[email protected]>; Elen Ohov (SoM) <[email protected]>; Thea Treier <[email protected]>; Kati Keel <[email protected]> Cc: Elen Nurme <[email protected]> Subject: Fwd: FW: Letter from EU Commissioner Stella Kyriakides to the Minister of Health and Labour, Social Affairs, Mr Tanel Kiik and to the Minister of Rural Affairs, Mr Urmas Kruuse. Tere, Edastan volinik Kyriakidese kirjad minister Kiigele ja minister Kruusele seoses veterinaarravimite määruse rakendamisega. Tervitades Algis ---------- Forwarded message ---------- From: Marten Kokk <[email protected]> Date: 29 Apr 2021 16:30 Subject: FW: Letter from EU Commissioner Stella Kyriakides to the Minister of Health and Labour, Social Affairs, Mr Tanel Kiik and to the Minister of Rural Affairs, Mr Urmas Kruuse. To: Algis Kokka <[email protected]> Cc: *** TÄHELEPANU *** See e-kiri (kaasa arvatud manused) on mõeldud ainult e-kirja adressaatidele ning võib sisaldada ametialaseks kasutamiseks ettenähtud teavet. Teavet ei tohi ilma saatja selgelt väljendatud loata edasi saata ega mistahes viisil kõrvalistele isikutele avaldada. Juhul, kui Te olete saanud käesoleva e-kirja eksituse tõttu, palun teavitage sellest kohe saatjat ning kustutage e-kiri oma arvutist. *** ATTENTION *** This e-mail and its attachments may contain official information. If you are not the intended recipient, please notify the sender immediately, delete this e-mail and destroy any copies. Any dissemination or use of this information by a person other than the intended recipient is unauthorized and may be unlawful. From: CASSAR Christian <[email protected]> Sent: Thursday, April 29, 2021 4:13 PM To: Marten Kokk <[email protected]> Cc: Tairi Täht <[email protected]>; Esindus EL juures üldaadress <[email protected]> Subject: Letter from EU Commissioner Stella Kyriakides to the Minister of Health and Labour, Social Affairs, Mr Tanel Kiik and to the Minister of Rural Affairs, Mr Urmas Kruuse. 1 Dear Ambassador, Please find attached a letter from EU Commissioner Stella Kyriakides to the Minister of Health and Labour, Social Affairs, Mr Tanel Kiik and to the Minister of Rural Affairs, Mr Urmas Kruuse, concerning veterinary medicinal products. Kind Regards Christian Cassar Assistant European Commission Cabinet of Commissioner Stella Kyriakides Health and Food Safety Rue de la Loi 200, BERL 10/390 B-1049 Brussels/Belgium Telephone: +32 2 29 88690 Email: [email protected] 2
Allikas: Sotsiaalministeerium dokumendiregister →